Abatacept in B7-1 Positive Proteinuric Kidney Disease
|
|
- Briana Cooper
- 6 years ago
- Views:
Transcription
1 correspondence practicing orthopedic surgeons, in which mechanical symptoms were not even included owing to the presumption that they would be unanimously considered a definite surgical indication. As noted by Jevsevar et al., the AAOS shares this stance. 1 However, compelling evidence is lacking to support the assumption that mechanical symptoms are caused by degenerative meniscal tears or that they can be alleviated by arthroscopic partial meniscectomy in these patients. Krych et al. state that subchondral edema and chondromalacia could affect the outcome of arthroscopic partial meniscectomy. Although this is possible, to our knowledge, no conclusive evidence exists to support such assumptions in this particular patient population. Reliable testing of hypotheses like these would require that criteria for these potential prognostic factors first be accepted and validated. In response to Lattermann et al.: we emphasize that FIDELITY was designed as an efficacy (proof-of-concept) trial with the intention of recruiting not typical patients undergoing arthroscopic partial meniscectomy but rather patients most likely to have a good response (those with a medial meniscal tear but no osteoarthritis). This also explains the lengthy recruitment period despite the participation of five high-volume centers. Although the study design has been elaborated in detail previously, 2 we briefly note that an efficacy trial assesses whether an intervention here, arthroscopic partial meniscectomy can theoretically work under the best circumstances. If the results are negative, this suggests that it is not necessary to assess effectiveness in less optimal, routine settings. 3 With respect to the concern that lavage was not an appropriate control, the existing high-quality evidence is unambiguous: tidal irrigation 4 and arthroscopic lavage 5 have failed to provide a benefit over sham procedures (sham irrigation and skin incisions, respectively) in randomized trials involving patients with osteoarthritis. The AAOS seems to endorse this view. 1 Teppo L.N. Järvinen, M.D., Ph.D. Helsinki University Central Hospital Helsinki, Finland teppo.jarvinen@helsinki.fi Raine Sihvonen, M.D. Hatanpää City Hospital Tampere, Finland Antti Malmivaara, M.D., Ph.D. National Institute for Health and Welfare Helsinki, Finland Since publication of their article, the authors report no further potential conflict of interest. 1. Jevsevar DS, Brown GA, Jones DL, et al. The American Academy of Orthopaedic Surgeons evidence-based guideline on: treatment of osteoarthritis of the knee, 2nd edition. J Bone Joint Surg Am 2013;95: Sihvonen R, Paavola M, Malmivaara A, Jarvinen TL. Finnish Degenerative Meniscal Lesion Study (FIDELITY): a protocol for a randomised, placebo surgery controlled trial on the efficacy of arthroscopic partial meniscectomy for patients with degenerative meniscus injury with a novel RCT within-a-cohort study design. BMJ Open 2013;3(3):pii:e Haynes B. Can it work? Does it work? Is it worth it? The testing of healthcare interventions is evolving. BMJ 1999;319: Bradley JD, Heilman DK, Katz BP, Gsell P, Wallick JE, Brandt KD. Tidal irrigation as treatment for knee osteoarthritis: a shamcontrolled, randomized, double-blinded evaluation. Arthritis Rheum 2002;46: Moseley JB, O Malley K, Petersen NJ, et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med 2002;347:81-8. DOI: /NEJMc Abatacept in B7-1 Positive Proteinuric Kidney Disease To the Editor: In their Brief Report, Yu et al. (Dec. 19 issue) 1 describe the use of abatacept, an inhibitor of the T-cell costimulatory molecule B7-1, in inducing remission in five patients with focal segmental glomerulosclerosis (FSGS) resistant to rituximab and glucocorticoids (one patient with primary FSGS and four with recurrent FSGS after transplantation). The rationale for using abatacept was that B7-1 is induced in podocytes in primary and recurrent FSGS as well as in patients with membranous nephropathy. In an attempt to reproduce their findings with the same antibodies, we found no B7-1 signal in samples obtained from patients with recurrent FSGS after transplantation and strong staining in samples obtained from patients with membranous nephropathy, results almost identical to those reported by Yu et al. However, sec- n engl j med 370;13 nejm.org march 27,
2 The new england journal of medicine Figure 1. Kidney-Biopsy Specimens Analyzed for the Detection of B7-1 with the Use of Two Secondary Antibodies. Shown are frozen sections of kidney obtained from patients with focal segmental glomerulosclerosis (FSGS) (left column), membranous nephropathy (MN) (middle column), or the uninvolved portion of kidney collected from a tumor nephrectomy sample (CTR) (right column). Sections were incubated with goat antihuman B7-1 or medium alone (as indicated by a minus sign), followed by either donkey antigoat secondary antibody (Alexa Fluor 488, Invitrogen) (Panel A) or rabbit antigoat secondary antibody (Jackson ImmunoResearch) (Panel B). tions that were treated with secondary antibody alone had exactly the same staining (Fig. 1), which suggests that the authors finding (as seen in Fig. S9H in the Supplementary Appendix, available with the full text of the article by Yu et al.) is probably an artifact, at least in the sample of membranous nephropathy. This is not surprising, since in membranous nephropathy, reactivity 1262 n engl j med 370;13 nejm.org march 27, 2014
3 correspondence of the secondary antibody with the IgG deposited in glomeruli often leads to false positive results. A different appropriately human IgG-adsorbed secondary antibody gave us no signal in FSGS and mild or absent staining in membranous nephropathy (Fig. 1). Thus, with the use of the appropriate reagents, B7-1 does not appear to be induced in FSGS and membranous nephropathy, so the antiproteinuric action of abatacept, if confirmed, may not be the result of an effect on podocyte B7-1. Ariela Benigni, Ph.D. Elena Gagliardini, Ph.D. Giuseppe Remuzzi, M.D. Istituto di Ricerche Farmacologiche Mario Negri Bergamo, Italy giuseppe.remuzzi@marionegri.it No potential conflict of interest relevant to this letter was reported. 1. Yu C-C, Fornoni A, Weins A, et al. Abatacept in B7-1 positive proteinuric kidney disease. N Engl J Med 2013;369: DOI: /NEJMc To the Editor: Yu et al. suggest a new pathway for drug action in patients with primary and recurrent FSGS. The authors report successful responses to abatacept on the basis of in vitro findings that the expression of B7-1 in podocytes resulted in the deactivation of β1-integrin and subsequent cellular injury. 1 We would like to share data with respect to five patients with FSGS after transplantation who did not have a response to plasmapheresis and rituximab and who subsequently received B7-1 blockers. The patients did not have positive therapeutic responses, despite positive podocyte B7-1 expression in their respective kidney-biopsy specimens (Table 1, and Table S1 in the Supplementary Appendix). The responses to abatacept in patients with recurrent FSGS who also received concurrent plasmapheresis, rituximab, and other immunosuppressive agents will require additional confirmation in prospective trials to study the role of B7-1 in FSGS. Nada Alachkar, M.D. Naima Carter-Monroe, M.D. Johns Hopkins University School of Medicine Baltimore, MD nalachk1@jhmi.edu Jochen Reiser, M.D., Ph.D. Rush University Medical Center Chicago, IL Dr. Reiser reports holding pending or issued patents on novel kidney-protective therapies with the possibility of royalties. No other potential conflict of interest relevant to this letter was reported. 1. Reiser J, von Gersdorff G, Loos M, et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 2004;113: DOI: /NEJMc The authors reply: We agree with Benigni and colleagues that donkey-derived secondary antibodies can react nonspecifically with human IgG, thereby masking specific B7-1 staining in immune complex mediated glomerulopathies. This problem can be avoided by using preabsorbed rabbit secondary antibodies (Fig. 1A). Using human tonsil B lymphocytes as a positive control and a nephrectomy specimen as a negative control, we confirmed specific podocyte B7-1 staining in a new series of native renal-biopsy specimens, including staining in specimens obtained from two of five patients with primary FSGS, from two of five patients with minimal change disease, and from two of four patients with membranous nephropathy (Fig. 1B). Benigni and colleagues report two patients with B7-1 negative recurrent FSGS but no positive control; since only a subgroup of patients with proteinuric kidney diseases are B7-1 positive, this is not unexpected, but care must be taken in the interpretation of negative B7-1 staining in the absence of positive controls. The key characteristics of all the patients presented by Alachkar and colleagues suggest that the correspondents have been misled in their conclusions by the comparisons they chose. In the absence of controls, B7-1 staining, as shown in their patients, is not a meaningful diagnostic procedure. Patients 1, 2, and 3 have results that are inconsistent with recurrent or newly diagnosed primary FSGS in the allograft but rather support a secondary cause, a situation in which we reported little to no relevance for B7-1. In Patient 1, the underlying native kidney disease is unknown. Specific B7-1 staining above background fluorescence is absent. Therefore, judgment regarding treatment outcomes with abatacept is not meaningful. In Patient 2, underlying native kidney disease is lupus nephritis, not FSGS, so comparisons with our results are not meaningful. In Patients 2 and 3, proteinuria at the time of diagnosis is well below the ne- n engl j med 370;13 nejm.org march 27,
4 The new england journal of medicine 1264 n engl j med 370;13 nejm.org march 27, 2014
5 correspondence phrotic range, which is very different from the status of our patients. In contrast to our approach, all their patients were treated either many weeks or many months after the onset of proteinuria, which precludes comparisons with our results. n engl j med 370;13 nejm.org march 27,
6 The new england journal of medicine Figure 1 (previous page). Podocyte B7-1 Detection in Human Kidney-Biopsy Specimens. Panel A shows a comparison of kidney-biopsy specimens that have been stained for B7-1 with the use of donkey or rabbit secondary antibodies. All specimens were obtained from patients who were described in our study. Although no significant difference is detected in a B7-1 negative control case (acute tubular necrosis [ATN]), a sample of membranous nephropathy (MN) shows intense nonspecific background staining of IgG in coarse granular immune deposits with the donkey secondary antibody (at left), which masks the specific, granular B7-1 staining that is revealed with the rabbit secondary antibody (at right). Panel B shows representative images of a previously unpublished series of kidney-biopsy specimens that have been stained for B7-1 and rabbit secondary antibody (B7-1) or for rabbit secondary antibody alone (control). Human tonsil, serving as a positive control, shows specific membrane staining for B7-1 in lymphocytes, whereas the control sample shows background fluorescence. A tumor nephrectomy specimen (tumor Nx), which serves as a negative control, shows no specific B7-1 staining. A subset of biopsy specimens from patients with FSGS, minimal change disease (MCD), or MN show positive (+) granular B7-1 staining that follows the glomerular basement membranes, whereas other samples from patients with these diseases are negative ( ) for B7-1. The focal, coarse background staining probably represents nonspecific autofluorescence in erythrocytes. The most fundamental difference between the findings of Alachkar et al. and our experience with abatacept is that Patients 2 through 5 in their study received belatacept. The therapeutic protocols for belatacept are very different from those for abatacept. As compared with abatacept, belatacept has markedly enhanced affinity for B7-2 (also called CD86). 1 Since podocytes do not express B7-2, and abatacept favors the inhibition of B7-1, 1 the distinct differences between abatacept and belatacept informed our choice to use abatacept for the treatment of podocyte B7-1 positive proteinuric kidney disease. We agree that prospective trials are necessary to further evaluate abatacept therapy in patients with B7-1 positive proteinuric kidney disease, and indeed such efforts are under way. Anna Greka, M.D., Ph.D. Massachusetts General Hospital Boston, MA Astrid Weins, M.D., Ph.D. Brigham and Women s Hospital Boston, MA Peter Mundel, M.D. Massachusetts General Hospital Boston, MA mundel.peter@mgh.harvard.edu Since publication of their article, Drs. Greka and Mundel report anticipated fees from BMS for the planning of a clinical trial, and Dr. Weins reports participation in negotiations with BMS to initiate a clinical trial. No further potential conflict of interest relevant to this letter was reported. This letter was updated on December 22, 2014, at NEJM.org. 1. Martin ST, Tichy EM, Gabardi S. Belatacept: a novel biologic for maintenance immunosuppression after renal transplantation. Pharmacotherapy 2011;31: DOI: /NEJMc Endotracheal Extubation To the Editor: It is well known that intravenous lidocaine can suppress coughing due to tracheal intubation. 1 But the statement in the Videos in Clinical Medicine review by Ortega et al. (Jan. 16 issue) 2 that local anesthetic agents in general can be used to treat coughing may lead to the false assumption that this is correct for all local anesthetic agents. The intravenous administration of local anesthetic agents other than lidocaine to prevent coughing may lead to life-threatening central nervous system and cardiac toxicity and should be definitely avoided. 3 Figure 1 of the Videos in Clinical Medicine review showed an oxygen mask, which allows a patient to breathe oxygen-enriched air but is not a device to provide mechanical ventilation. It would have been useful to reference modern video-based intubating devices 4 as a step in the management of the difficult airway before cricothyroidotomy. Alexander Avidan, M.D. Hadassah Hebrew University Medical Center Jerusalem, Israel alex@avidan.co.il No potential conflict of interest relevant to this letter was reported. 1. Yukioka H, Yoshimoto N, Nishimura K, Fujimori M. Intravenous lidocaine as a suppressant of coughing during tracheal intubation. Anesth Analg 1985;64: Ortega R, Connor C, Rodriguez G, Spencer C. Videos in clinical medicine: endotracheal extubation. N Engl J Med 2014; 370(3):e4. 3. Wolfe JW, Butterworth JF. Local anesthetic systemic toxicity: 1266 n engl j med 370;13 nejm.org march 27, 2014
Protocol. This trial protocol has been provided by the authors to give readers additional information about their work.
Protocol This trial protocol has been provided by the authors to give readers additional information about their work. Protocol for: Sihvonen R, Paavola M, Malmivaara A, et al. Arthroscopic partial meniscectomy
More informationThe renal glomeruli are highly specialized structures that ensure
Brief Report Abatacept in B7-1 Positive Proteinuric Kidney Disease Chih-Chuan Yu, M.Sc., Alessia Fornoni, M.D., Ph.D., Astrid Weins, M.D., Ph.D., Samy Hakroush, M.D., Dony Maiguel, Ph.D., Junichiro Sageshima,
More informationCase Presentation Turki Al-Hussain, MD
Case Presentation Turki Al-Hussain, MD Director, Renal Pathology Chapter Saudi Society of Nephrology & Transplantation Consultant Nephropathologist & Urological Pathologist Department of Pathology & Laboratory
More informationHumber. Arthroscopy Knee
Humber Arthroscopy Knee Intervention Diagnostic & Therapeutic Arthroscopy Knee OPCS Codes W85 Therapeutic endoscopic operations on cavity of knee joint W851 Endoscopic removal of loose body from knee joint
More informationRENAL EVENING SPECIALTY CONFERENCE
RENAL EVENING SPECIALTY CONFERENCE Harsharan K. Singh, MD The University of North Carolina at Chapel Hill Disclosure of Relevant Financial Relationships No conflicts of interest to disclose. CLINICAL HISTORY
More informationNon-Surgical vs. Surgical Treatment of Meniscus Tears of the Knee
Non-Surgical vs. Surgical Treatment of Meniscus Tears of the Knee Greg I. Nakamoto, MD FACP Section of Orthopedics and Sports Medicine Virginia Mason Medical Center CASE 1 45 y/o construction worker sent
More informationManagement of the Early Degenerate Knee. Kieran Barnard Hip and Knee Pathway Lead
Management of the Early Degenerate Knee Kieran Barnard Hip and Knee Pathway Lead This history Moseley et al (2002) Randomised placebo controlled trial. A total of 180 patients with osteoarthritis of the
More informationNew Ideas. Better Medicines. Third Quarter Financial Results Conference Call
New Ideas. Better Medicines. Third Quarter 2018 Financial Results Conference Call Forward-Looking Statements 2 This presentation contains forward-looking statements that involve substantial risks and uncertainties.
More informationCase 3. ACCME/Disclosure. Laboratory results. Clinical history 4/13/2016
Case 3 Lynn D. Cornell, M.D. Mayo Clinic, Rochester, MN Cornell.Lynn@mayo.edu USCAP Renal Case Conference March 13, 2016 ACCME/Disclosure Dr. Cornell has nothing to disclose Clinical history 57-year-old
More informationUrinary CD80 as a Replacement for Renal Biopsy for Diagnosis of Pediatric Minimal Change Disease
KIDNEY DISEASES Urinary CD80 as a Replacement for Renal Biopsy for Diagnosis of Pediatric Minimal Change Disease Heba Mostafa Ahmed, 1 Dina Ahmed Ezzat, 1 Noha A Doudar, 2 Mai Adel 1 1 Departement of Pediatrics,
More informationReview of Rituximab and renal transplantation. Dr.E Nemati. Professor of Nephrology
Review of Rituximab and renal transplantation Dr.E Nemati Professor of Nephrology Introductio n Rituximab is a chimeric anti-cd20 monoclonal antibody. The CD20 antigen is a transmembrane nonglycosylated
More informationGlomerular Pathology- 1 Nephrotic Syndrome. Dr. Nisreen Abu Shahin
Glomerular Pathology- 1 Nephrotic Syndrome Dr. Nisreen Abu Shahin The Nephrotic Syndrome a clinical complex resulting from glomerular disease & includes the following: (1) massive proteinuria (3.5 gm /day
More informationDr Ian Roberts Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust
Dr Ian Roberts Oxford Oxford Pathology Course 2010 for FRCPath Present the basic diagnostic features of the commonest conditions causing proteinuria & haematuria Highlight diagnostic pitfalls Nephrotic
More informationArthroscopic Partial Meniscectomy versus Sham Surgery for a Degenerative Meniscal Tear
The new england journal of medicine original article Arthroscopic Partial Meniscectomy versus Sham Surgery for a Degenerative Meniscal Tear Raine Sihvonen, M.D., Mika Paavola, M.D., Ph.D., Antti Malmivaara,
More informationElevated Serum Creatinine, a simplified approach
Elevated Serum Creatinine, a simplified approach Primary Care Update Creighton University School of Medicine. April 27 th, 2018 Disclosure Slide I have no disclosures and have no conflicts with this presentation.
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Yu C-C, Fornoni A, Weins A, et al. Abatacept in B7-1 positive
More informationNHS Birmingham and Solihull Clinical Commissioning Group. DRAFT Policy for Knee Arthroscopy for Degenerative Knee Disease
NHS Birmingham and Solihull Clinical Commissioning Group DRAFT Policy for Knee Arthroscopy for Degenerative Knee Disease 1 Document Details: Version: DRAFT v3. Ratified by (name and date of Committee):
More informationAn unusual association between focal segmental sclerosis and lupus nephritis: a distinct concept from lupus podocytopathy?
CEN Case Rep (2015) 4:70 75 DOI 10.1007/s13730-014-0142-1 CASE REPORT An unusual association between focal segmental sclerosis and lupus nephritis: a distinct concept from lupus podocytopathy? Hironari
More informationDr Ian Roberts Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust
Dr Ian Roberts Oxford Oxford Pathology Course 2010 for FRCPath Plan of attack: Diagnostic approach to the renal biopsy Differential diagnosis of the clinical syndromes of renal disease Microscopy Step
More informationRecurrent Idiopathic Membranous Glomerulonephritis After Kidney Transplantation and Successful Treatment With Rituximab
TRANSPLANTATION Recurrent Idiopathic Membranous Glomerulonephritis After Kidney Transplantation and Successful Treatment With Rituximab Khadijeh Makhdoomi, 1,2 Saeed Abkhiz, 1,2 Farahnaz Noroozinia, 1,3
More informationPodocyte Biology and clinical applications Dr. F. Ahmadi Professor Of Nephrology TUMS
Podocyte Biology and clinical applications Dr. F. Ahmadi Professor Of Nephrology TUMS Proteinuria is a major healthcare problem that affects several hundred million people worldwide. Proteinuria is a cardinal
More informationOverview of glomerular diseases
Overview of glomerular diseases *Endothelial cells are fenestrated each fenestra: 70-100nm in diameter Contractile, capable of proliferation, makes ECM & releases mediators *Glomerular basement membrane
More informationRenal Pathology 1: Glomerulus. With many thanks to Elizabeth Angus PhD for EM photographs
Renal Pathology 1: Glomerulus With many thanks to Elizabeth Angus PhD for EM photographs Anatomy of the Kidney http://www.yalemedicalgroup.org/stw/page.asp?pageid=stw028980 The Nephron http://www.beltina.org/health-dictionary/nephron-function-kidney-definition.html
More informationA clinical syndrome, composed mainly of:
Nephritic syndrome We will discuss: 1)Nephritic syndrome: -Acute postinfectious (poststreptococcal) GN -IgA nephropathy -Hereditary nephritis 2)Rapidly progressive GN (RPGN) A clinical syndrome, composed
More informationBiopsy Features of Kidney Allograft Rejection Banff B. Ivanyi, MD Department of Pathology, University of Szeged, Szeged, Hungary
Biopsy Features of Kidney Allograft Rejection Banff 2017 B. Ivanyi, MD Department of Pathology, University of Szeged, Szeged, Hungary Treatment of allograft dysfunction should rely on the biopsy findings
More informationMonoclonal Gammopathies and the Kidney. Tibor Nádasdy, MD The Ohio State University, Columbus, OH
Monoclonal Gammopathies and the Kidney Tibor Nádasdy, MD The Ohio State University, Columbus, OH Monoclonal gammopathy of renal significance (MGRS) Biopsies at OSU (n=475) between 2007 and 2016 AL or AH
More informationThe Society for Patient Centered Orthopedics. Choosing Wisely List. James Rickert, MD 1
The Society for Patient Centered Orthopedics Choosing Wisely List James Rickert, MD 1 Extremities and Trauma Vertebroplasty Rotator Cuff Repair: For atraumatic (degenerative) tears in patients greater
More informationTHSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity
OPEN Official journal of the United States and Canadian Academy of Pathology. 0893-3952/16 421 THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity
More informationUse of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome
Pediatr Nephrol (2003) 18:833 837 DOI 10.1007/s00467-003-1175-4 BRIEF REPORT Gina-Marie Barletta William E. Smoyer Timothy E. Bunchman Joseph T. Flynn David B. Kershaw Use of mycophenolate mofetil in steroid-dependent
More informationSubmission for The Knee. Title: Arthroscopic washout of the knee: A procedure in decline
Submission for The Knee Title: Arthroscopic washout of the knee: A procedure in decline Authors: Stefan Lazic 1, Oliver Boughton 1, Caroline Hing 1, Jason Bernard 1 1 St George s Hospital, Tooting, London,
More informationChapter 6: Idiopathic focal segmental glomerulosclerosis in adults Kidney International Supplements (2012) 2, ; doi: /kisup.2012.
http://www.kidney-international.org chapter 6 & 2012 KDIGO Chapter 6: Idiopathic focal segmental glomerulosclerosis in adults Kidney International Supplements (2012) 2, 181 185; doi:10.1038/kisup.2012.19
More informationCase # 2 3/27/2017. Disclosure of Relevant Financial Relationships. Clinical history. Clinical history. Laboratory findings
Case # 2 Christopher Larsen, MD Arkana Laboratories Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to influence or control the content
More informationC1q nephropathy the Diverse Disease
C1q nephropathy the Diverse Disease Danica Galešić Ljubanović School of Medicine, University of Zagreb Dubrava University Hospital Zagreb, Croatia Definition Dominant or codominant ( 2+), mesangial staining
More informationFIBRILLARY GLOMERULONEPHRITIS DIAGNOSTIC CRITERIA, PITFALLS, AND DIFFERENTIAL DIAGNOSIS
FIBRILLARY GLOMERULONEPHRITIS DIAGNOSTIC CRITERIA, PITFALLS, AND DIFFERENTIAL DIAGNOSIS Guillermo A. Herrera MD Louisiana State University, Shreveport Fibrils in bundles 10-20 nm d Diabetic fibrillosis
More informationProf. Franco Ferrario Nephropathology Unit Department of Pathology San Gerardo Hospital Università Milan Bicocca Monza, Italy.
The role of repeated biopsies in the management of Lupus Nephritis Franco Ferrario, Milan, Italy Chairs: David Jayne, Cambridge, UK Vladimir Tesar, Prague, Czech Republic Prof. Franco Ferrario Nephropathology
More informationAtypical IgA Nephropathy
Atypical IgA Nephropathy Richard J. Glassock, MD, MACP Geffen School of Medicine at UCLA XXXIII Chilean Congress of Nephrology, Hypertension and Transplantation Puerto Varas, Chile October 6, 2016 IgA
More informationPriorities Forum Statement GUIDANCE
Priorities Forum Statement Number 21 Subject Knee Arthroscopy including arthroscopic knee washouts Date of decision November 2016 Date refreshed March 2017 Date of review November 2018 Osteoarthritis of
More informationClinical pathological correlations in AKI
Clinical pathological correlations in AKI Dr. Rajasekara chakravarthi Director - Nephrology Star Kidney Center, Star Hospitals Renown clinical services India Introduction AKI is common entity Community
More informationInteresting case seminar: Native kidneys Case Report:
Interesting case seminar: Native kidneys Case Report: Proximal tubulopathy and light chain deposition disease presented as severe pulmonary hypertension with right-sided cardiac dysfunction and nephrotic
More informationNephrotic syndrome minimal change disease vs. IgA nephropathy. Hadar Meringer Internal medicine B Sheba
Nephrotic syndrome minimal change disease vs. IgA nephropathy Hadar Meringer Internal medicine B Sheba The Case 29 year old man diagnosed with nephrotic syndrome 2 weeks ago and complaining now about Lt.flank
More informationManagement of Rejection
Management of Rejection I have no disclosures Disclosures (relevant or otherwise) Deborah B Adey, MD Professor of Medicine University of California, San Francisco Kidney and Pancreas Transplant Center
More informationRENAL HISTOPATHOLOGY
RENAL HISTOPATHOLOGY Peter McCue, M.D. Department of Pathology, Anatomy & Cell Biology Sidney Kimmel Medical College There are no conflicts of interest. 1 Goals and Objectives! Goals Provide introduction
More informationClinical Commissioning Policy: Rituximab for the treatment of idiopathic membranous nephropathy in adults
Clinical Commissioning Policy: Rituximab for the treatment of idiopathic membranous nephropathy in adults Reference: NHS England: 16047/P NHS England INFORMATION READER BOX Directorate Medical Operations
More informationMembranous nephropathy. By Mohammed Kamal Nassar, MD Lecturer of Nephrology Mansoura University
Membranous nephropathy By Mohammed Kamal Nassar, MD Lecturer of Nephrology Mansoura University Membranous nephropathy Definition: Immune complex glomerular disease in which immune deposits of IgG and complement
More informationManagement and treatment of glomerular diseases KDIGO Controversies Conference Part 1
Management and treatment of glomerular diseases KDIGO Controversies Conference Part 1 Dr.M.Matinfar Assistant Professor of Internal Medicine & Nephrology IUMS -IKRC GENERAL PRINCIPLES IN THE MANAGEMENT
More informationGlomerular Diseases. Anna Vinnikova, MD Nephrology
Glomerular Diseases Anna Vinnikova, MD Nephrology Classification of Glomerular Diseases http://what-when-how.com/acp-medicine/glomerular-diseases-part-1/ Classification of pathologic and clinical manifestations
More informationLupus Related Kidney Diseases. Jason Cobb MD Assistant Professor Renal Division Emory University School of Medicine October 14, 2017
Lupus Related Kidney Diseases Jason Cobb MD Assistant Professor Renal Division Emory University School of Medicine October 14, 2017 Financial Disclosures MedImmune Lupus Nephritis Kidney Biopsy Biomarkers
More informationHistopathology: Glomerulonephritis and other renal pathology
Histopathology: Glomerulonephritis and other renal pathology These presentations are to help you identify basic histopathological features. They do not contain the additional factual information that you
More informationGlomerular diseases mostly presenting with Nephritic syndrome
Glomerular diseases mostly presenting with Nephritic syndrome 1 The Nephritic Syndrome Pathogenesis: proliferation of the cells in glomeruli & leukocytic infiltrate Injured capillary walls escape of RBCs
More informationFocal Segmental Glomerulosclerosis and the Nephro6c Syndrome Dr. A. Gangji Dr. P. Marge>s. Part 1: Clinical
Focal Segmental Glomerulosclerosis and the Nephro6c Syndrome Dr. A. Gangji Dr. P. Marge>s Part 1: Clinical Pa#ent DM 18 year old McMaster student Back pain, severe fa#gue Oct 2006 Leg swelling to ER Nov
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Jones RB, Cohen Tervaert JW, Hauser T, et al. Rituximab versus
More informationTHE URINARY SYSTEM. The cases we will cover are:
THE URINARY SYSTEM The focus of this week s lab will be pathology of the urinary system. Diseases of the kidney can be broken down into diseases that affect the glomeruli, tubules, interstitium, and blood
More informationTHE URINARY SYSTEM. The cases we will cover are:
THE URINARY SYSTEM The focus of this week s lab will be pathology of the urinary system. Diseases of the kidney can be broken down into diseases that affect the glomeruli, tubules, interstitium, and blood
More informationLONG-TERM OUTCOME OF PATIENTS WITH LUPUS NEPHRITIS: A SINGLE CENTER EXPERIENCE
& LONG-TERM OUTCOME OF PATIENTS WITH LUPUS NEPHRITIS: A SINGLE CENTER EXPERIENCE Senija Rašić 1 *, Amira Srna 1, Snežana Unčanin 1, Jasminka Džemidžić 1, Damir Rebić 1, Alma Muslimović 1, Maida Rakanović-Todić
More informationJoint Theater Trauma System Clinical Practice Guideline
Page 1 of 7 Joint Theater Trauma System Clinical Practice Guideline TRAUMA AIRWAY MANAGEMENT Original Release/Approval 18 Dec 2004 Note: This CPG requires an annual review. Reviewed: May 2012 Approved:
More informationManagement of Nephrotic Syndrome
Management of Nephrotic Syndrome Treatment Strategies and Current Therapeutic Options Brad H. Rovin MD, FASN Professor of Medicine and Pathology Director, Division of Nephrology 1 DISCLOSURE STATEMENTS
More informationRECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT. J. H. Helderman,MD,FACP,FAST
RECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT J. H. Helderman,MD,FACP,FAST Vanderbilt University Medical Center Professor of Medicine, Pathology and Immunology Medical Director, Vanderbilt Transplant
More informationSTEROID-RESISTANT NEPHROTIC SYNDROME (SRNS)
MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH CLINICAL RESEARCH CENTRE FOR RARE DISEASES ALDO E CELE DACCO' Villa Camozzi - 24020 Ranica (Bergamo) Italy Telephone 39-35-4535304 fax 39-35-4535373 STEROID-RESISTANT
More informationOut of date SUGGESTIONS FOR CLINICAL CARE (Suggestions are based on level III and IV evidence)
Membranous nephropathy role of cyclosporine therapy Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES a. The use of cyclosporine therapy alone to prevent progressive
More informationArthroscopic Debridement of the Knee: An Evidence Update
Arthroscopic Debridement of the Knee: An Evidence Update Evidence Development and Standards Branch, Health Quality Ontario November 2014 Ontario Health Technology Assessment Series; Vol. 14: No. 13, pp.
More informationPathology of Complement Mediated Renal Disease
Pathology of Complement Mediated Renal Disease Mariam Priya Alexander, MD Associate Professor of Pathology GN Symposium Hong Kong Society of Nephrology July 8 th, 2017 2017 MFMER slide-1 The complement
More informationArthroscopic knee washout, with or without debridement, for the treatment of osteoarthritis
Arthroscopic knee washout, with or without debridement, for the treatment of osteoarthritis Issued: August 2007 www.nice.org.uk/ipg230 Copyright NICE 2007 Contents 1 Guidance... 3 2 The procedure... 4
More informationSurvivorship After Meniscal Allograft Transplantation According To Articular Cartilage Status
# 154134 Survivorship After Meniscal Allograft Transplantation According To Articular Cartilage Status Jun-Gu Park, Seong-Il Bin, Jong-Min Kim, Bum Sik Lee Department of Orthopaedic Surgery, Asan Medical
More informationNEPHROTIC SYNDROME SYMPOSIUM
NEPHROTIC SYNDROME SYMPOSIUM NOVEMBER 4, 2016 8:30 AM - 3:40 PM The New York Academy of Medicine 1216 Fifth Avenue New York, NY 10029 COURSE DIRECTORS Gerald B. Appel, MD Columbia University College of
More informationDiabetes, Obesity and Heavy Proteinuria
Diabetes, Obesity and Heavy Proteinuria Clinical Case 41 yo Black woman with heavy proteinuria History 2014: noted to have proteinuria on routine lab testing (1.1g/g). 1+ edema. Blood pressure has been
More informationSecondary IgA Nephropathy & HSP
Secondary IgA Nephropathy & HSP Anjali Gupta, MD 1/11/11 AKI sec to Hematuria? 65 cases of ARF after an episode of macroscopic hematuria have been reported in the literature in patients with GN. The main
More informationCHAPTER 2. Primary Glomerulonephritis
2nd Report of the PRIMARY GLOMERULONEPHRITIS CHAPTER 2 Primary Glomerulonephritis Sunita Bavanandan Lee Han Wei Lim Soo Kun 21 PRIMARY GLOMERULONEPHRITIS 2nd Report of the 2.1 Introduction This chapter
More informationSurgical Pathology Report
Louisiana State University Health Sciences Center Department of Pathology Shreveport, Louisiana Accession #: Collected: Received: Reported: 6/1/2012 09:18 6/2/2012 09:02 6/2/2012 Patient Name: Med. Rec.
More informationBariatric Surgery versus Intensive Medical Therapy for Diabetes 3-Year Outcomes
The new england journal of medicine original article Bariatric Surgery versus Intensive Medical for Diabetes 3-Year Outcomes Philip R. Schauer, M.D., Deepak L. Bhatt, M.D., M.P.H., John P. Kirwan, Ph.D.,
More informationHasan Fattah 3/19/2013
Hasan Fattah 3/19/2013 AASK trial Rational: HTN is a leading cause of (ESRD) in the US, with no known treatment to prevent progressive declines leading to ESRD. Objective: To compare the effects of 2 levels
More informationGlomerular pathology-2 Nephritic syndrome. Dr. Nisreen Abu Shahin
Glomerular pathology-2 Nephritic syndrome Dr. Nisreen Abu Shahin 1 The Nephritic Syndrome Pathogenesis: inflammation proliferation of the cells in glomeruli & leukocytic infiltrate Injured capillary walls
More informationRituximab in Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome
CLINICAL RESEARCH www.jasn.org Rituximab in Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome Piero Ruggenenti,* Barbara Ruggiero,* Paolo Cravedi,* Marina Vivarelli, Laura Massella,
More informationChapter 4: Steroid-resistant nephrotic syndrome in children Kidney International Supplements (2012) 2, ; doi: /kisup.2012.
http://www.kidney-international.org & 2012 KDIGO Chapter 4: Steroid-resistant nephrotic syndrome in children Kidney International Supplements (2012) 2, 172 176; doi:10.1038/kisup.2012.17 INTRODUCTION This
More informationYear 2004 Paper one: Questions supplied by Megan
QUESTION 53 Endothelial cell pathology on renal biopsy is most characteristic of which one of the following diagnoses? A. Pre-eclampsia B. Haemolytic uraemic syndrome C. Lupus nephritis D. Immunoglobulin
More informationCHAPTER 2 PRIMARY GLOMERULONEPHRITIS
CHAPTER 2 Sunita Bavanandan Lim Soo Kun 19 5th Report of the 2.1: Introduction This chapter covers the main primary glomerulonephritis that were reported to the MRRB from the years 2005-2012. Minimal change
More informationEmergency Department/Trauma Adult Airway Management Protocol
Emergency Department/Trauma Adult Airway Management Protocol Purpose: A standardized protocol for management of the airway in the setting of trauma in an academic center, with the goal of maximizing successful
More informationOrdering Physician. Collected REVISED REPORT. Performed. IgG IF, Renal MCR. Lambda IF, Renal MCR. C1q IF, Renal. MCR Albumin IF, Renal MCR
RenalPath Level IV Wet Ts IgA I Renal IgM I Renal Kappa I Renal Renal Bx Electron Microscopy IgG I Renal Lambda I Renal C1q I Renal C3 I Renal Albumin I Renal ibrinogen I Renal Mayo Clinic Dept. of Lab
More informationTreatment of MGN A roundtable discussion based on best evidence Drs Cattran Expert Panel Dr Ruggenenti,Falk,Ponticelli,Fervenza,Remuzzi
Treatment of MGN A roundtable discussion based on best evidence Drs Cattran Expert Panel Dr Ruggenenti,Falk,Ponticelli,Fervenza,Remuzzi Level 1 2 3 4 5 6 Definition of evidence Randomized, controlled trial
More informationFinnish Degenerative Meniscal Lesion Study (FIDELITY): a protocol for a. blinded, randomised placebo surgery controlled
Open Access To cite: Sihvonen R, Paavola M, Malmivaara A, et al. Finnish Degenerative Meniscal Lesion Study (FIDELITY): a protocol for a randomised, placebo surgery controlled trial on the efficacy of
More informationFinnish Degenerative Meniscal Lesion Study (FIDELITY): a protocol for a. blinded, randomised placebo surgery controlled
Open Access To cite: Sihvonen R, Paavola M, Malmivaara A, et al. Finnish Degenerative Meniscal Lesion Study (FIDELITY): a protocol for a randomised, placebo surgery controlled trial on the efficacy of
More informationBiology Of Renal Tubulo-Interstitial Cells (Experimental Nephrology, 5-6)
Biology Of Renal Tubulo-Interstitial Cells (Experimental Nephrology, 5-6) If you are searched for the book Biology of Renal Tubulo- Interstitial Cells (Experimental Nephrology, 5-6) in pdf format, in that
More informationGenetics of Steroid Resistant Nephrotic syndrome. Velibor Tasic University Children s Hospital Skopje, Macedonia
Genetics of Steroid Resistant Nephrotic syndrome Velibor Tasic University Children s Hospital Skopje, Macedonia Nephrotic syndrome - definition Oedema Massive proteinuria (> 50mg/kg/d or> 40mg/m2/h Hypoalbuminemia
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Membranous nephropathy role of steroids GUIDELINES
Membranous nephropathy role of steroids Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES There is currently no data to support the use of short-term courses of
More informationClassification of Glomerular Diseases and Defining Individual Glomerular Lesions: Developing International Consensus
Classification of Glomerular Diseases and Defining Individual Glomerular Lesions: Developing International Consensus Mark Haas MD, PhD Department of Pathology & Laboratory Medicine Cedars-Sinai Medical
More informationSCOTTISH REAL BIOPSY REGISTRY: SURVEY OF NATIVE KIDNEY BIOPSY IN SCOTLAND 2015
Scottish Renal Registry Report SECTION N SCOTTISH REAL BIOPSY REGISTRY: SURVEY OF NATIVE KIDNEY BIOPSY IN SCOTLAND All centres in Scotland were able to provide date of birth, sex (except centre), indication
More informationKDIGO Controversies Conference on Glomerular Diseases
KDIGO Controversies Conference on Glomerular Diseases November 16-19, 2017 Singapore Kidney Disease: Improving Global Outcomes (KDIGO) is an international organization whose mission is to improve the care
More informationTHE KIDNEY AND SLE LUPUS NEPHRITIS
THE KIDNEY AND SLE LUPUS NEPHRITIS JACK WATERMAN DO FACOI 2013 NEPHROLOGY SIR RICHARD BRIGHT TERMINOLOGY RENAL INSUFFICIENCY CKD (CHRONIC KIDNEY DISEASE) ESRD (ENDSTAGE RENAL DISEASE) GLOMERULONEPHRITIS
More informationSecond Injury and Enhancement Fund [SIEF] (preexisting condition).
SUMMARY DECISION NO. 1423/97 Second Injury and Enhancement Fund [SIEF] (preexisting condition). The worker suffered a knee injury in March 1995. A torn meniscus was diagnosed and the worker underwent arthroscopic
More informationArthroscopic partial meniscectomy versus placebo surgery for a degenerative meniscus tear
https://helda.helsinki.fi Arthroscopic partial meniscectomy versus placebo surgery for a degenerative meniscus tear Sihvonen, Raine 2018-02 Sihvonen, R, Paavola, M, Malmivaara, A, Itälä, A, Joukainen,
More informationResistant Nephrotic Syndrome: Review of Trials Using ACTH and a Case Series of Six Patients Treated with ACTHar
British Journal of Medicine & Medical Research 5(11): 1453-1457, 2015, Article no.bjmmr.2015.164 ISSN: 2231-0614 SCIENCEDOMAIN international www.sciencedomain.org Resistant Nephrotic Syndrome: Review of
More informationRenal Data from the Arab World
Saudi J Kidney Dis Transpl 2013;24(2):387-391 2013 Saudi Center for Organ Transplantation Saudi Journal of Kidney Diseases and Transplantation Renal Data from the Arab World Pattern of Glomerular Diseases
More informationNew Evidence Suggests that Work Related Knee Pain with Degenerative Complications May Not Require Surgery
4 th Quarter 2017 New Evidence Suggests that Work Related Knee Pain with Degenerative Complications May Not Require Surgery By: Michael Erdil MD, FACOEM Introduction It is estimated there are approximately
More informationMr. I.K 58 years old
Mr. I.K 58 years old Hospitalized because of marked pitting peripheral edema (bilateral crural and perimalleolar edema) and uncontrolled blood pressure (BP 150/100 mmhg under treatment). since age 54 years
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Specific management of IgA nephropathy: role of steroid therapy GUIDELINES
Specific management of IgA nephropathy: role of steroid therapy Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES Steroid therapy may protect against progressive
More informationC3 GLOMERULOPATHIES. Budapest Nephrology School Zoltan Laszik
C3 GLOMERULOPATHIES Budapest Nephrology School 8.30.2018. Zoltan Laszik 1 Learning Objectives Familiarize with the pathogenetic mechanisms of glomerular diseases Learn the pathologic landscape and clinical
More informationThe ERA-EDTA database on recurrent glomerulonephritis following renal transplantation
Nephrol Dial Transplant (2014) 29: 15 21 doi: 10.1093/ndt/gft299 Advance Access publication 27 August 2013 NDT Perspectives The ERA-EDTA database on recurrent glomerulonephritis following renal transplantation
More informationHRZZ project: Genotype-Phenotype correlation in Alport's syndrome and Thin Glomerular Basement Membrane Nephropathy. Patohistological Aspects
HRZZ project: Genotype-Phenotype correlation in Alport's syndrome and Thin Glomerular Basement Membrane Nephropathy Patohistological Aspects Petar Šenjug, MD 1 Professor Danica Galešić Ljubanović, MD,
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Idiopathic membranous nephropathy: use of other therapies GUIDELINES
Idiopathic membranous nephropathy: use of other therapies Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES No recommendations possible based on Level I or II evidence
More informationDense deposit disease with steroid pulse therapy
Case Report Dense deposit disease with steroid pulse therapy Jun Odaka, Takahiro Kanai, Takane Ito, Takashi Saito, Jun Aoyagi, and Mariko Y Momoi Abstract Treatment of dense deposit disease DDD has not
More informationRATIONALE. K Without therapy, ANCA vasculitis with GN is associated. K There is high-quality evidence for treatment with
http://www.kidney-international.org chapter 13 & 2012 KDIGO Chapter 13: Pauci-immune focal and segmental necrotizing glomerulonephritis Kidney International Supplements (2012) 2, 233 239; doi:10.1038/kisup.2012.26
More information